Compass Pathways Leads the Way as the First Psychedelics Company to IPO on the Nasdaq
September 24, 2020 (MicroSmallCap via Comtex) — Last year may have been all about cannabis, but it’s clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since Johnson & Johnson’s (NYSE:JNJ) ketamine-derived ... [Read]